Insider · CIK 0001710625

Lemercier Jean-Luc M

Reports to the SEC for 1 company · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001710625

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-07	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−82 sh	$92.32	−$7,570.24	184,685.805
2024-05-11	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−21 sh	$86.72	−$1,821.12	184,767.806
2024-05-07	EWEdwards Lifesciences CorpA Award	CVP, EMEACLA and JAPAC	AAward	+7,125 sh	—	—	184,834.806
2024-05-07	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−46 sh	$85.09	−$3,914.14	184,788.806
2024-05-07	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)A Award	CVP, EMEACLA and JAPAC	AAward	+42.2K sh	—	—	42,200
2024-05-07	EWEdwards Lifesciences Corp · Performance RightsA Award	CVP, EMEACLA and JAPAC	AAward	+7,125 sh	—	—	7,125
2024-05-06	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−259 sh	$85.25	−$22.1K	177,709.806
2024-05-04	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+4,157 sh	—	—	177,968.806
2024-05-04	EWEdwards Lifesciences Corp · Performance RightsM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−4,157 sh	—	—	0
2024-05-03	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−37 sh	$85.06	−$3,147.22	173,811.806
2024-05-01	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+14.4K sh	$36.75	+$529K	188,248.806
2024-05-01	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−2,160 sh	$84.83	−$183K	186,088.806
2024-05-01	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−12.2K sh	$84.11	−$1.03M	173,848.806
2024-05-01	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−14.4K sh	—	—	0
2024-04-08	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+14.4K sh	$36.75	+$529K	188,248.806
2024-04-08	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−107 sh	$92.65	−$9,913.55	188,141.806
2024-04-08	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−14.3K sh	$92.32	−$1.32M	173,848.806
2024-04-08	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−14.4K sh	—	—	14,400
2024-03-11	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+14.4K sh	$36.75	+$529K	187,983.779
2024-03-11	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−14.4K sh	$91.68	−$1.32M	173,583.779
2024-03-11	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−14.4K sh	—	—	28,800
2023-07-07	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−81 sh	$90.46	−$7,327.26	173,583.779
2023-05-11	EWEdwards Lifesciences CorpA Award	CVP, EMEACLA and JAPAC	AAward	+1,575 sh	—	—	173,664.779
2023-05-11	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)A Award	CVP, EMEACLA and JAPAC	AAward	+13.3K sh	—	—	13,300
2023-05-11	EWEdwards Lifesciences Corp · Performance RightsA Award	CVP, EMEACLA and JAPAC	AAward	+1,975 sh	—	—	1,975
2023-05-09	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+6,640 sh	$35.20	+$234K	178,729.779
2023-05-09	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−6,640 sh	$88.68	−$589K	172,089.779
2023-05-09	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−6,640 sh	—	—	0
2023-05-08	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−104 sh	$88.74	−$9,228.96	172,089.779
2023-05-07	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+3,355 sh	—	—	172,417.779
2023-05-07	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−224 sh	$88.74	−$19.9K	172,193.779
2023-05-07	EWEdwards Lifesciences Corp · Performance RightsM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−3,355 sh	—	—	920
2023-05-04	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−38 sh	$88.10	−$3,347.8	169,062.779
2023-05-03	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−37 sh	$87.81	−$3,248.97	169,100.779
2023-04-06	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+6,640 sh	$35.20	+$234K	175,777.779
2023-04-06	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−6,640 sh	$83.10	−$552K	169,137.779
2023-04-06	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−6,640 sh	—	—	6,640
2023-03-08	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+6,640 sh	$35.20	+$234K	175,514.87
2023-03-08	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−50 sh	$77.43	−$3,871.5	175,464.87
2023-03-08	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−6,590 sh	$76.95	−$507K	168,874.87
2023-03-08	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−6,640 sh	—	—	13,280
2022-07-07	EWEdwards Lifesciences CorpA Award	CVP, EMEACLA and JAPAC	AAward	+6,100 sh	—	—	168,874.87
2022-07-07	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)A Award	CVP, EMEACLA and JAPAC	AAward	+54.5K sh	—	—	54,500
2022-07-07	EWEdwards Lifesciences Corp · Performance RightsA Award	CVP, EMEACLA and JAPAC	AAward	+7,625 sh	—	—	7,625
2022-05-17	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−143 sh	$95.93	−$13.7K	162,756.34
2022-05-09	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+11.6K sh	$21.76	+$252K	174,459.34
2022-05-09	EWEdwards Lifesciences CorpS Sale	CVP, EMEACLA and JAPAC	SSale	−11.6K sh	$98.24	−$1.14M	162,899.34
2022-05-09	EWEdwards Lifesciences Corp · Employee Stock Option (Right to Acquire)M Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	−11.6K sh	—	—	0
2022-05-08	EWEdwards Lifesciences CorpM Exercise/Conversion	CVP, EMEACLA and JAPAC	MExercise/Conversion	+8,531 sh	—	—	163,514.34
2022-05-08	EWEdwards Lifesciences CorpF Tax Payment	CVP, EMEACLA and JAPAC	FTax Payment	−615 sh	$100.52	−$61.8K	162,899.34

Recent filings

Accepted (ET)
Jul 84
Lemercier Jean-Luc M0001225208-24-007359
SEC(opens sec.gov)
May 134
Lemercier Jean-Luc M0001225208-24-005982
SEC(opens sec.gov)
May 94
Lemercier Jean-Luc M0001225208-24-005888
SEC(opens sec.gov)
May 64
Lemercier Jean-Luc M0001225208-24-005702
SEC(opens sec.gov)
May 14
Lemercier Jean-Luc M0001225208-24-005437
SEC(opens sec.gov)
Apr 84
Lemercier Jean-Luc M0001225208-24-005005
SEC(opens sec.gov)
Mar 114
Lemercier Jean-Luc M0001225208-24-004035
SEC(opens sec.gov)

Companies

Edwards Lifesciences CorpCVP, EMEACLA and JAPACEW

Address

ONE EDWARDS WAY

IRVINE, CA, 92614